Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pakistan Pharmas Call For 20 Percent Increase In Allowed Drug Prices

This article was originally published in PharmAsia News

Executive Summary

The Pakistan Pharmaceutical Manufacturers Association is calling for a 20 percent increase in the allowed prices for drugs in the country. The industry cites added costs of raw materials and energy as well as the devalued Pakistani currency as reasons for allowing a price hike. The group said lifting the cap on drug prices was essential if the nation's drug-making industry is to survive. The PPMA estimated lifting the caps would save Pakistan the $3 billion cost of importing foreign-made drugs that comprise more than 90 percent of drugs available in the country. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069982

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel